Trial intelligence / Profile preview

Microfragmented Adipose Tissue vs Hyaluronic Acid for TMJ Osteoarthritis

NCT06425263Not yet recruiting

Sponsor
Cairo University
Start
Jun 2024
Primary completion
Sep 2024
Modality
Cell Therapies
01

Overview

Randomised, open-label trial of microfragmented adipose tissue in temporomandibular joint osteoarthritis (2 arms), sponsored by Cairo University. Primary endpoint: Visual Analog Scale at 3 months. Planned start Jun 2024; status: not yet recruiting.

02

Drugs

microfragmented adipose tissue
03

Conditions

temporomandibular joint osteoarthritis

Beyond the preview

Go deeper on NCT06425263.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06425263.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call